Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
Provided By GlobeNewswire
Last update: Aug 27, 2025
SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.
Read more at globenewswire.com
